Middle East, North Africa, Afghanistan & Pakistan (excluding high income) vs Zimbabwe: Access to anti-retroviral drugs, male
Access to anti-retroviral drugs, male over time
- Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
- Zimbabwe
How they compare
Zimbabwe currently reports 89.0% against 22.9% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income), a difference of 66.1%.
That makes Zimbabwe's figure about 3.9 times Middle East, North Africa, Afghanistan & Pakistan (excluding high income)'s.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ahead.
Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 18th and Zimbabwe ranks 17th of 19 groups.
Zimbabwe has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Middle East, North Africa, Afghanistan & Pakistan (excluding high income) | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.3% | 4.1% | 0.8% | Zimbabwe |
| 2010s | 10.3% | 52.9% | 42.6% | Zimbabwe |
| 2020s | 19.4% | 88.4% | 69.0% | Zimbabwe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Middle East, North Africa, Afghanistan & Pakistan (excluding high income) or Zimbabwe?
- Zimbabwe, at 89.0% against 22.9% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Zimbabwe?
- 66.1%, with Zimbabwe ahead.
- How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Zimbabwe?
- 25 years are reported by both, from 2000 to 2024.
- How do Middle East, North Africa, Afghanistan & Pakistan (excluding high income) and Zimbabwe rank globally for access to anti-retroviral drugs, male?
- Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 18th and Zimbabwe ranks 17th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.